| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/12/2009 | CN101502579A Chinese medicinal composition for treating digestive tumor and preparation method thereof |
| 08/12/2009 | CN101502545A Method for preparing Chinese medicine for resisting cancer and treating cancer ache |
| 08/12/2009 | CN101502532A Application of triple spiral Dictyophora phalloidea polysaccharide |
| 08/12/2009 | CN101502531A 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatites virus infections |
| 08/12/2009 | CN101502524A Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN101502523A Application of benzoyl fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN101502508A Application of 5-oxo-4-alkenylene-pyrazole derivative in preparing anti-tumor medicament |
| 08/12/2009 | CN101502506A Medical use of 3-(3,4-dihydroxyphenyl)-acrylic acid 2-(3,4-dihydroxyphenyl)-ethyl ester |
| 08/12/2009 | CN101502503A Application of fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN101502498A Curcumin preparation for percutaneous administration and preparation method thereof |
| 08/12/2009 | CN101502488A Teniposide emulsion and preparation method thereof |
| 08/12/2009 | CN101502486A Antineoplastic 2-methoxyestradiol injection containing cyclodextrin or cyclodextrin derivates |
| 08/12/2009 | CN101502484A Glucocorticosteroid and chemotherapy medicament carried by anticancer sustained-release agent |
| 08/12/2009 | CN100526463C Methods for making Apo-2 ligand using divalent metal ions |
| 08/12/2009 | CN100526331C CTL epitopes from EBV |
| 08/12/2009 | CN100526330C Fasciation naematoloma ligarine extraction, preparing method thereof and use in preparing pharmaceutical for treating tumour |
| 08/12/2009 | CN100526324C Process for the preparation of trans- or cis-diammoniumdichlorodihydroxyplatinum(IV) salts and derivatives and their use for the preparation of pharmaceutical active agents |
| 08/12/2009 | CN100526317C Gambogicacid derivative and its preparation method and uses in pharmacy |
| 08/12/2009 | CN100526316C Triazole miazines derivative |
| 08/12/2009 | CN100526315C N2-quinoline or isoquinoline substituted purine derivative and its preparation method and uses |
| 08/12/2009 | CN100526312C Benzimidazole quinolinones and uses thereof |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525837C Application of cytoplasm targeting administration system capable of reversing tumor cell resistance |
| 08/12/2009 | CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 08/12/2009 | CN100525803C Medical use of iris |
| 08/12/2009 | CN100525782C Tetraselmis chui polysaccharide protein possessing antineoplastic function |
| 08/12/2009 | CN100525769C Sustained release formulation of raltitrexed and preparation method thereof |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/12/2009 | CN100525758C Garcinolic acid liposome and freezing-drying powdery preparation and its making method |
| 08/12/2009 | CN100525756C Coated ubenimex table |
| 08/12/2009 | CN100525748C New preparation of medicine, its preparation and application method |
| 08/12/2009 | CN100525631C Non invasive measurements of chemical substances |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572923 Indirubin derivatives having anticancer property against human cancer cell line |
| 08/11/2009 | US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine |
| 08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 08/11/2009 | US7572891 Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572882 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/11/2009 | US7572826 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572804 Macrolides |
| 08/11/2009 | US7572800 Administering anti-hepatitis B virus agents in combination or alternation such asbeta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl-1,3-oxathiolane or a salt and one another antihepatitis B agent |
| 08/11/2009 | US7572799 Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine |
| 08/11/2009 | US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy |
| 08/11/2009 | US7572778 recognize and bind the tubulin site: antitubulin; useful for treating pathological states which arise from or are exacerbated by cell proliferation as anticancer and/or antiangiogenic activity |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572633 Use of the adenoviral E2 late promoter |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
| 08/11/2009 | US7572436 Thionin as an antineoplastic and immunostimulant |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
| 08/11/2009 | CA2321263C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/07/2009 | CA2643611A1 Biomarkers for head-and-neck cancers and precancers |
| 08/06/2009 | WO2009097578A1 Oxim derivatives as hsp90 inhibitors |
| 08/06/2009 | WO2009097570A2 Intralymphatic chemotherapy drug carriers |
| 08/06/2009 | WO2009097490A1 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES |
| 08/06/2009 | WO2009097446A1 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 08/06/2009 | WO2009097351A2 TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE STRANDED RNAs |
| 08/06/2009 | WO2009097233A1 Imidazopyrazines as protein kinase inhibitors |
| 08/06/2009 | WO2009097128A1 Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 08/06/2009 | WO2009097095A2 Methods for treating hematopoietic malignancies |
| 08/06/2009 | WO2009096905A1 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
| 08/06/2009 | WO2009096789A1 Composition for stimulating natural killer cell activity |
| 08/06/2009 | WO2009096772A1 Composition for stimulating natural killer cell activity |
| 08/06/2009 | WO2009096487A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 08/06/2009 | WO2009096435A1 Condensed heterocyclic derivatives and uses thereof |
| 08/06/2009 | WO2009096377A1 Combined use of angiogenesis inhibitor and taxane |
| 08/06/2009 | WO2009096245A1 Pharmaceutical composition and combined agent |
| 08/06/2009 | WO2009096198A1 Novel biaryl derivative |
| 08/06/2009 | WO2009096196A1 Method for determination of sensitivity to anti-cancer agent |
| 08/06/2009 | WO2009096189A1 Marker for determination of sensitivity to anti-cancer agent |
| 08/06/2009 | WO2009095916A2 Cd14 and peptides thereof for protection of cells against cell death |
| 08/06/2009 | WO2009095872A2 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 08/06/2009 | WO2009095796A2 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | WO2009095583A2 Use of aminopeptidase inhibitors or azaindole compounds for preventing or treating cancerous metastases from epithelial origin |
| 08/06/2009 | WO2009095499A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 08/06/2009 | WO2009095480A1 Improved antitumoral treatments |
| 08/06/2009 | WO2009095399A2 Pyrazine derivatives and their use as protein kinase inhbitors |
| 08/06/2009 | WO2009095324A1 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/06/2009 | WO2009095261A2 Vaccine compositions |
| 08/06/2009 | WO2009095254A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/06/2009 | WO2009095033A1 Vaccine compositons |
| 08/06/2009 | WO2009094958A1 Saccharide lupane derivatives, their use and pharmaceutical compositions containing these derivatives |
| 08/06/2009 | WO2009094850A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof |
| 08/06/2009 | WO2009094752A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094751A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009075841A3 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 08/06/2009 | WO2009074811A3 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 08/06/2009 | WO2009068625A3 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |